Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation"
- PMID: 29020494
- DOI: 10.1080/09273948.2017.1371312
Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation"
Comment in
-
Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".Ocul Immunol Inflamm. 2019;27(1):71. doi: 10.1080/09273948.2017.1379545. Epub 2017 Oct 18. Ocul Immunol Inflamm. 2019. PMID: 29043914 No abstract available.
Comment on
-
Adalimumab for Ocular Inflammation.Ocul Immunol Inflamm. 2017 Jun;25(3):405-412. doi: 10.3109/09273948.2015.1134581. Epub 2016 Mar 22. Ocul Immunol Inflamm. 2017. PMID: 27003323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous